Cannabis Radio News

DEA Approves Syndros® THC Oral Solution as Schedule II

Informações:

Synopsis

DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug has received approval for placement in Schedule II classification by the DEA.